Closing Glance: Biotechnology stocks fall

Shares of biotechnology companies closed mostly lower Tuesday as the broader market wavered following a weak April retail sales report from the Commerce Department and an oil price spike to a new record near $127 a barrel.

Here's how several key biotechnology stocks performed Tuesday:

Celgene Corp., down $1.42, or 2.3 percent, to $60.31.

Amgen Inc., down 45 cents to $42.50.

Biogen Idec Inc., down 73 cents, to $62.32.

Genentech Inc., up 18 cents to $68.55.